DAFTAR PUSTAKA
1. El-Zimaity HMT. Recent advances in the histopathology of gastritis. Current
Diagnostic Pathology. 2007;13:340-8.
2. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human
pathology. 2005;36:228-33.
3. Faturrahman, Nurdjanah S, Ratnasai N. Perbedaan ekspresi Interleukin-10
berdasrkan keparahan lesi mukosa gaster dari gastritis kronik dengan infeks
Helicobacter Pylori. Electronic Thesis & Dissetation. Universitas Gajah
Mada..2013.http://etd.ac.id
4. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. The Journal of
Clinical
5. Cesar ACG, Cury PM, Payao SLM. Comparison of histological and molecular
diagnosis of Helicobacter pylori in benign lesions and gastric adenocarcinoma.
Braz J Microbiol. 2005;36(1):261-6.
6. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, et
al. Decreasing prevalence of helicobacter antibodies in Finland, with reference
to the decreasing incidence of gastric cancer. Epidemiol Infect.
2001;126:37-42.
7. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al.
Genetic differences in interleukin-1 betapolymorphisms among four Asian
populations: an analysis of the Asian paradox between H. pylori infection and
gastric cancer incidence. J Exp Clin Cancer Res. 2003; 22: 47-55.
8. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP, et al.
Gastric mucosal cytokine responses in Helicobacter pylori-infected patients
with gastritis and peptic ulcers. Association with inflammatory parameters and
bacteria load. FEMS Immunology and Medical Microbiology.
2003;36:175-80.
9. Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al.
Relationship between gastric mucosal IL-8 levels and histological gastritis in
patients with Helicobacter pylori infection. Tokai J Exp Clin Med.
10. Andersen LP, Holck S, Janulaityte-Gu¨nther D, Kupcinskas L, Kiudelis G,
Jonaitis L, et al. Gastric inflammatory markers and interleukins in patients
with functional dyspepsia, with and without Helicobacter pylori infection.
FEMS Immunology and Medical Microbiology.2005;44:233–8.
11. Lundin BS, Enarsson K, Kindlund B, Lundgren A, Johnsson E,
Quiding-Jarbrink M, et al. The local and systemic T-cell response to Helicobacter
pylori in gastric cancer patients is characterised by production of interleukin-10. Clin Immunol. 2007;125: 205-13.
12. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H,
Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, et al: Lansoprazole, a
Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factoralpha
and Interleukin-1beta Induced by Lipopolysaccharide and Helicobacter Pylori
Bacterial Components in Human Monocytic Cells via Inhibition of Activation
of Nuclear Factor-kappaB and Extracellular Signal-Regulated Kinase. J Clin
Biochem Nutr. 2009, 45(1):86–92.
13. Lee HJ, Han YM, Kim EH, Kim YJ, Hahm KB. A possible involvement of
Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the
proton pump inhibitor pantoprazole against indomethacin-induced gastric
damage in rats. BMC Gastroenterology. 2012;12:143.
14. Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng (Kudingcha)
prevents HCl/ethanol induced gastric injury in Sprague Dawley rats.
Molecular Medicine Reports. 2013;7:1613-6.
15. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal
Publishing : 2009 ; 509-512
16. Pratomo BW. Gastritis dan gastropati dalam buku ajar gastroenterologi. Edisi
I. Internal publishing. 2011:307-311
17. S Iiyas. Repository.usu.ac.id.2013
18. Mayo clinic. Gastritis.2014[ diunduh 14 Mei 2014]. Terseia dari
:http://www.mayoclinic.org
19. Wehbi M. Acute gastritis. Medscape. 2014
20. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, et al.
Gastritis: the histology report. Digestive and Liver Disease. 2011; 43S:S373–
21. Adibi P. Gastritis. [Diunduh 19 Mei 2014]. Tersedia dari:
22. Dixon MF, Genta RM, Yardley H, Correa P. Classification and grading of
gastritis: the updated Sydney system. Am J Surg Pathol. 1996;20:1161–81.
23. Guindy AE, Ghoraba H. A study of the concordance between endoscopic
gastritis and histological gastritis in nonulcer dyspeptic patients with and
without Helicobacter pylori infection. Tanta Medical Sciences Journal.
2007;2(2):67-82.
24. Szoke D. Genetic factors related to the histological and macroscopic lesions of
the stomach. [disertasi]. Budapest: Semmelweis University; 2009. Hlm 7-61.
25. Toljamo K. Gastric erosions – clinical significance and pathology. A
long-term follow-up study. University of Oulu, Finland:Acta Univ Oul; 2012.hlm
1-80.
26. Zakaria Z. The role of interleukin-10 in Helicobacter pylori infection. Master
[Tesis]. Nottingham,UK: University of Nottingham; 2010.hlm. 55.
27. Adam B, et al. Cellular immune activation and clinical manifestation of
funcional dyspepsia. Z Gastroenterol 2008;46-v26
28. Elseweidy MM. Helicobacter pylori ifection and its relevant to chronic
gastritis. INTECH.2013.http://dx.doi.org/105772/46056
29. D W, Chey, C B, Wong. American college of gastroenterology guidline on the
management of H.pylori infetion. Am J Gastroenterol 2007;102:1808-1825
30. Lew E. Peptic ulcer disease. In: Greenberger NJ, editor. Current Diagnosis and
Treatment Gastroenterology, Hepatology, and Endoscopy. New York:
McGraw Hill; 2009.hlm.175-83.
31. Simadibrata M. Dyspepsia and Gastroesophageal Reflux Disease (GERD): Is
There Any Correlation? Acta Med Indones. 2009; 41(4): 222-7.
32. Silva MIG, de Sousa FCF. Gastric ulcer etiology. In: Chai J, editor. Peptic
Ulcer Disease. Shanghai: Intech; 2011. hlm. 3-28.
33. Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar S.
Unveiling the Intricacies of Helicobacter pylori-induced Gastric Inflammation:
T Helper cells and Matrix Metalloproteinases at a Crossroad. In: Mozsik G,
editor. Current Topics in Gastritis. Croatia: InTech Publishers; 2013. Chapter
34. Rakananurak N, Sallapant S, Prueksapanich P, Somanawat K, Klaikaew N,
Rerknimitr R, et al. Aloe vera Improved Gastric Injury on Nonsteroidal
Anti-Inflammatory Drugs-Induced Gastropathy in Rats. Thai J Gastroenterol. 2013;
14(2):87-92.
35. Eamlamnam K, Patumraj S, Visedopas N, et al. Effects of Aloe vera and
sucralfate on gastric microcirculatory changes, cytokine levels and gastric
ulcer healing in rats. World J Gastroenterol. 2006;12:2034-9.
36. Naito Y, Yoshikawa T, Yagi N, Matsuyama K, Yoshida N, Seto K, et al.
Effects of polaprezinc on lipid peroxidation, neutrophil accumulation, and
TNF- expression in rats with aspirin-induced gastric mucosal injury. Dig Dis
Sci. 2001;46:845–51.
37. Jainu M, Devi CSS. Gastroprotective action of Cissus quadrangularis extract
against NSAID induced gastric ulcer: role of proinflammatory cytokines and
oxidative damage. Chem Biol Interact. 2006;161:262–70.
38. Konturek PC, Duda A, Brzozowski T, Konturek SJ, Kwiecien S, Drozdowicz
D, et al. Activation of genes for superoxide dismutase, interleukin-1beta,
tumor necrosis factor-alpha, and intercellular adhesion molecule-1 during
healing of ischemia-reperfusion-induced gastric injury. Scand J Gastroenterol.
2000;35(5):452-63.
39. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter
pylori-induced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90.
40. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. British
Med Bull. 1998;54:139-50.
41. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H.
Interleukin 1beta polymorphisms increase risk of hypochlorhydria and
atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.
Gastroenterology. 2002;123(1):92-105.
42. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS. Interleukin-10 signaling
blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA
binding. J Biol Chem. 1999;274:31868-74.
43. Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR. The role of
NF-kappaB in mediating the anti-inflammatory effects of IL-10 in intestinal
44. Mege j l,et al. The two face of Interleukin 10 in human infectious
diseases.Lancet Infection Dis;2006:6:557-69
45. Abdollahi H, et al. IL-10, TNF-α, IFN-γ in serum and stomach mucosa in
H.Pylori infected patients. Iran J Allergy and Imunnology. Des
2011;(10)4:267-271
46. Sutton P,et al.Dominant nonresponsiveness to Helicobacter Pylori infection is
associated with production of IL-10 but not gamma interferon. Infection and
Immunity,Aug,2000;4802-4804
47. Mitchell P J, et al. Helicobacter Pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin 1-β production by dendritic cell. British society for immunology, clinical and experimental immunology,
2012;170:300-309
48. Rad R, Schmid RM, Kusters JG, Backert S, Gerhard M, Prinz C,et al.
Helicobacter pylori outer membrane proteins and gastric
inflamtion.Gut,2006;55::1360-1372
49. Bodger K, etal. Interleukin 10 in H.Pylori associated gastritis :
immunohistochemical localisation and in vitro effects on cytokine secretion. J
Clin Pathol 2001:54:285-292
50. Dahlan MS. Statistik untuk kedokteran dan kesehatan.Salemba
Medika.2012;3:26.
51. Kandulski A,Malfertheiner P, Wex T. Role of regulatory Tcells in H.Pylori –
induced gastritis and gastric cancer.Anticancer research 30;2010:1093-1104
52. Pandeya N, Whitmen DC, Australian Cancer Study. Prevalence and
determinants of H.Pylori sero-positivity in the australian community. J
Gastroenterologi Hepatology.2011 Aug;26(8);1283-9
53. Zhu Y, et al. Risk factors and prevalence of H.Pylori infection in persistent
high incidence area of gastric carcinoma in Yangzhong city.2014.
.http://dx.doi.org/10.1155/2014/481365
54. Naja F,et al. Helicobacter pylori in Ontario : prevalence and rsik factors.Jurnal
canadian of gastroenterologi,2007;21(8):501-506
55. Goll R, gruber F, Olsen T, Cui G, Raschpcher G, Buset M, et al.Helicobacter
pylori stimulate a mixed adaptive imun respon with a strong T regulatory
